
GMAB Market Capitalization Overview
Market Cap: $13.17B as of Jul 11, 2025
$13.17B
Past Month-$878.36M (6.26%)
As of Jul 11, 2025, GMAB has a market capitalization of $13.17B. Over the past 30 days, its market cap has decreased by -4.68%, while in the last 12 months, it has decreased by -0.72%.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMAB helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GMAB Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GMAB helps investors assess the company's size and compare it with competitors for better investment decisions.
GMAB Market Cap & Key Trends
See Genmab - ADR’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in GMAB
Order type
Buy in
Order amount
Est. shares
0 shares
GMAB Market Cap History
Date | Market Cap | Change |
---|---|---|
Jul 1, 2025 | $12.76B | -4.68% |
Jun 2, 2025 | $13.39B | +4.02% |
May 1, 2025 | $12.87B | +8.50% |
Apr 1, 2025 | $11.86B | -18.73% |
Mar 3, 2025 | $14.60B | +20.20% |
Feb 3, 2025 | $12.14B | -9.00% |
Jan 2, 2025 | $13.35B | -3.83% |
GMAB End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $13.17B | -0.72% |
2024 | $13.26B | -36.26% |
2023 | $20.80B | -24.92% |
2022 | $27.71B | +7.03% |
2021 | $25.89B | -2.69% |
2020 | $26.60B | — |
FAQs About Genmab - ADR (GMAB) Market Cap
As of Jul 11, 2025, the market capitalization of GMAB is $13.17B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Genmab - ADR’s market capitalization has decreased by -6.26%, changing from $14.05B to $13.17B as of Jul 11, 2025.
In the last 3 months, Genmab - ADR’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Genmab - ADR’s market capitalization decreased from $20.80B in January to $13.26B in December, reflecting a -36.26% change.
In the past five years, GMAB has had a compound annual growth rate (CAGR) of -13.00% in market capitalization. This means its market cap has shrunk at an average rate of -13.00% per year.